Portfolio Update

RNS Number : 4134X

Intl. Biotechnology Trust PLC

13 August 2009

 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC    

Portfolio update as at 31 July 2009                    

Total Net Assets	£95.1m
NAV per share	146.7p
Share Price	116.8p
Total value of unquoted investments	£19.5m
Total number of portfolio companies	59
Cash	3%
Cash committed and reserved to unquoted investments	13%
Portfolio companies with < 1 year of cash	19%

Top Ten Holdings

Company Name	% NAV	Market Value
Micromet	9.56	9,089,885
Celgene	6.25	5,940,971
Amgen	5.76	5,482,769
Gilead Sciences	4.79	4,557,382
Alexion Pharmaceuticals	3.31	3,146,634
EV3	3.08	2,928,118
Halozyme Therapeutics	2.69	2,556,049
Wright Medical	2.56	2,430,984
Affymax	2.53	2,409,427
Oxagen	2.52	2,396,053
	-----------	--------------
Total	43.05	40,938,272

Geographical Allocation	%
United States	80
Europe	16
Cash	3
Australia	1
	-----------
Total	100

Quoted/Unquoted allocation	%
Quoted	77
Unquoted	20
Cash	3
	-----------
	100

BNP Paribas Secretarial Services Limited

Company Secretary

13 AUGUST 2009

 

END

 

 

PFUBXGDIGXBGGCX